Skip to content

Fossil Group FOSL Licensing Income — Contract Liabilities

Similar metrics at other companies

Supernus Pharmaceuticals logo
SUPNLicense — Contract Liabilities
$90M
Maui Land & Pineapple logo
MLPLicense — Contract With Customer Liability Revenue Recognized
$33.33K0.0%
Nuvation Bio logo
NUVBLicense — Deferred Revenue
$58.7M
Zevra Therapeutics, Inc. logo
ZVRALicense — Contract with customer, liability, revenue recognized, including opening balance
$1.1M
Harley-Davidson logo
HOGLicensing — Revenue recognized over remaining contract term
$0
The ONE Group Hospitality logo
STKSLicense — Deferred Revenue
$109K-43.5%

Other financials

Income statement

See full
Revenue$224.8M-3.7%
Gross profit$134.7M-5.8%
Operating income$12.0M+279%
Net income-$677.0K+96.2%
EPS (diluted)-$0.01+97.0%

Balance sheet

See full
Cash & equivalents$84.2M+3.6%
Total debt$334.1M+3.7%
Total equity$99.1M-29.5%
Total assets$654.5M-4.6%

Cash flow

See full
Operating cash flow-$21.8M+63.9%
CapEx$949.0K+233%
Free cash flow-$22.7M+62.5%

Valuation

See full
Market cap$244.68M+215%
Enterprise value$494.68M+82.0%
P/S0.3×+0.2×

Profitability

See full
Gross margin55.7%+1.7pp
Operating margin-0.1%-0.1pp
Net margin-6.1%-1.5pp
FCF margin-7.8%-13.0pp

Returns & leverage

See full
Return on equity-50.6%-3.0pp
Debt / equity3.4×+1.1×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Fossil Group in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.

The official record: Fossil Group’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fossil Group's licensing income — contract liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fossil Group's licensing income — contract liabilities?
Fossil Group (FOSL) reported licensing income — contract liabilities of $300K in Q1 2026.
What does licensing income — contract liabilities mean?
This metric represents the deferred revenue or contract liabilities associated with licensing agreements where the company grants third parties the right to use its brand intellectual property. It reflects the portion of consideration received from licensees that has not yet been recognized as revenue because the underlying performance obligations have not been fully satisfied. Monitoring this balance provides insight into the future revenue pipeline generated from brand partnerships and the timing of royalty recognition.